Ionis Pharmaceuticals
IONS
IONS
336 hedge funds and large institutions have $4.92B invested in Ionis Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 114 increasing their positions, 107 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
3% less funds holding
Funds holding: 346 → 336 (-10)
11% less capital invested
Capital invested by funds: $5.53B → $4.92B (-$618M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
336
Holding in Top 10
4
Calls
$15.2M
Puts
$12.8M
Top Buyers
| 1 | +$46.3M | |
| 2 | +$45.5M | |
| 3 | +$30.9M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$28M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$24.8M |
Top Sellers
| 1 | -$66.1M | |
| 2 | -$39.3M | |
| 3 | -$19.1M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$18M |
| 5 |
Goldman Sachs
New York
|
-$13.9M |